August 30, 2016 4:17 AM ET


Company Overview of BioNumerik Pharmaceuticals, Inc.

Company Overview

BioNumerik Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of drugs for the treatment of cancer and cancer supportive care. Its products include Tavocept for oncology and non-oncology indications; and Karenitecin, a new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company also has other oncology research programs, including preclinical development programs in the areas of DNA methyltransferase modulators, novel platinum drugs, small molecule Bcl-2 inhibitors, novel taxane formulations, small molecule inhibitors for mitotic arrest, neuro and nephro-toxicity protection agents, and additional karenitecin class molecules. The company was...

8122 Datapoint Drive

Suite 1250

San Antonio, TX 78229

United States

Founded in 1992

67 Employees





Key Executives for BioNumerik Pharmaceuticals, Inc.

Founder, Chief Executive Officer and President
Age: 60
Chief Administrative Officer, Vice President of Administration and General Counsel
Age: 55
Vice President of Drug Process Development & Manufacturing and Project Manager
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BioNumerik Pharmaceuticals, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at